Table of Contents

2019-2024 Global Subcutaneous Immunotherapy Market Report (Status and Outlook)

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Subcutaneous Immunotherapy Market Size 2014-2024
2.1.2 Subcutaneous Immunotherapy Market Size CAGR by Region
2.2 Subcutaneous Immunotherapy Segment by Type
2.2.1 Asthma
2.2.2 Allergic Rhinitis
2.2.3 Venom Allergy
2.2.4 Food Allergy
2.3 Subcutaneous Immunotherapy Market Size by Type
2.3.1 Global Subcutaneous Immunotherapy Market Size Market Share by Type (2014-2019)
2.3.2 Global Subcutaneous Immunotherapy Market Size Growth Rate by Type (2014-2019)
2.4 Subcutaneous Immunotherapy Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Online Pharmacies
2.4.3 Retail Pharmacies
2.5 Subcutaneous Immunotherapy Market Size by Application
2.5.1 Global Subcutaneous Immunotherapy Market Size Market Share by Application (2014-2019)
2.5.2 Global Subcutaneous Immunotherapy Market Size Growth Rate by Application (2014-2019)

3 Global Subcutaneous Immunotherapy by Players
3.1 Global Subcutaneous Immunotherapy Market Size Market Share by Players
3.1.1 Global Subcutaneous Immunotherapy Market Size by Players (2017-2019)
3.1.2 Global Subcutaneous Immunotherapy Market Size Market Share by Players (2017-2019)
3.2 Global Subcutaneous Immunotherapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Subcutaneous Immunotherapy by Regions
4.1 Subcutaneous Immunotherapy Market Size by Regions
4.2 Americas Subcutaneous Immunotherapy Market Size Growth
4.3 APAC Subcutaneous Immunotherapy Market Size Growth
4.4 Europe Subcutaneous Immunotherapy Market Size Growth
4.5 Middle East & Africa Subcutaneous Immunotherapy Market Size Growth

5 Americas
5.1 Americas Subcutaneous Immunotherapy Market Size by Countries
5.2 Americas Subcutaneous Immunotherapy Market Size by Type
5.3 Americas Subcutaneous Immunotherapy Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Subcutaneous Immunotherapy Market Size by Countries
6.2 APAC Subcutaneous Immunotherapy Market Size by Type
6.3 APAC Subcutaneous Immunotherapy Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Subcutaneous Immunotherapy by Countries
7.2 Europe Subcutaneous Immunotherapy Market Size by Type
7.3 Europe Subcutaneous Immunotherapy Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Subcutaneous Immunotherapy by Countries
8.2 Middle East & Africa Subcutaneous Immunotherapy Market Size by Type
8.3 Middle East & Africa Subcutaneous Immunotherapy Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Subcutaneous Immunotherapy Market Forecast
10.1 Global Subcutaneous Immunotherapy Market Size Forecast (2019-2024)
10.2 Global Subcutaneous Immunotherapy Forecast by Regions
10.2.1 Global Subcutaneous Immunotherapy Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Subcutaneous Immunotherapy Forecast by Type
10.8 Global Subcutaneous Immunotherapy Forecast by Application

11 Key Players Analysis
11.1 Anergis
11.1.1 Company Details
11.1.2 Subcutaneous Immunotherapy Product Offered
11.1.3 Anergis Subcutaneous Immunotherapy Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Anergis News
11.2 HAL Allergy Group
11.2.1 Company Details
11.2.2 Subcutaneous Immunotherapy Product Offered
11.2.3 HAL Allergy Group Subcutaneous Immunotherapy Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 HAL Allergy Group News
11.3 Merck
11.3.1 Company Details
11.3.2 Subcutaneous Immunotherapy Product Offered
11.3.3 Merck Subcutaneous Immunotherapy Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 Merck News
11.4 Allergy Therapeutics
11.4.1 Company Details
11.4.2 Subcutaneous Immunotherapy Product Offered
11.4.3 Allergy Therapeutics Subcutaneous Immunotherapy Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 Allergy Therapeutics News
11.5 ALK-Abello
11.5.1 Company Details
11.5.2 Subcutaneous Immunotherapy Product Offered
11.5.3 ALK-Abello Subcutaneous Immunotherapy Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 ALK-Abello News
11.6 Stallergenes Greer
11.6.1 Company Details
11.6.2 Subcutaneous Immunotherapy Product Offered
11.6.3 Stallergenes Greer Subcutaneous Immunotherapy Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 Stallergenes Greer News
11.7 Laboratorios LETI
11.7.1 Company Details
11.7.2 Subcutaneous Immunotherapy Product Offered
11.7.3 Laboratorios LETI Subcutaneous Immunotherapy Revenue, Gross Margin and Market Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 Laboratorios LETI News
...

12 Research Findings and Conclusion